Found: 13
Select item for more details and to access through your institution.
Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 5513, doi. 10.1007/s00432-022-04473-5
- By:
- Publication type:
- Article
Therapeutic Interaction of Apatinib and Chidamide in T-cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic Apoptosis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 10, p. 977, doi. 10.3390/jpm11100977
- By:
- Publication type:
- Article
Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 15, doi. 10.3390/ph16010015
- By:
- Publication type:
- Article
Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 11, p. 1313, doi. 10.3390/ph15111313
- By:
- Publication type:
- Article
Pharmacological targeting PIKfyve and tubulin as an effective treatment strategy for double-hit lymphoma.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-00833-9
- By:
- Publication type:
- Article
Effect of prior lenalidomide or daratumumab exposure on hematopoietic stem cell collection and reconstitution in multiple myeloma.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 3839, doi. 10.1007/s00277-024-05683-2
- By:
- Publication type:
- Article
Anlotinib suppresses the DNA damage response by disrupting SETD1A and inducing p53-dependent apoptosis in Transformed Follicular Lymphoma.
- Published in:
- International Journal of Medical Sciences, 2024, v. 21, n. 1, p. 70, doi. 10.7150/ijms.84952
- By:
- Publication type:
- Article
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.780118
- By:
- Publication type:
- Article
CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.618908
- By:
- Publication type:
- Article
Foreign Object Detection in Railway Images Based on an Efficient Two-Stage Convolutional Neural Network.
- Published in:
- Computational Intelligence & Neuroscience, 2022, p. 1, doi. 10.1155/2022/3749635
- By:
- Publication type:
- Article
Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00282-1
- By:
- Publication type:
- Article
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
- Published in:
- 2022
- By:
- Publication type:
- Letter
How Do Customers Respond to Digital Banking Products and Services in New Zealand?
- Published in:
- Ege Academic Review, 2023, v. 23, n. 1, p. 27, doi. 10.21121/eab.980841
- By:
- Publication type:
- Article